Ipswich Investment Management Co. Inc. purchased a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,771 shares of the pharmacy operator’s stock, valued at approximately $121,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Cornerstone Advisors Inc. lifted its position in shares of Walgreens Boots Alliance by 102.4% during the 3rd quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 214 shares during the last quarter. BlueMountain Capital Management LLC purchased a new stake in Walgreens Boots Alliance during the 2nd quarter worth about $103,000. Asset Dedication LLC raised its holdings in shares of Walgreens Boots Alliance by 204.6% in the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after acquiring an additional 1,060 shares in the last quarter. Capital Advisors Ltd. LLC raised its holdings in shares of Walgreens Boots Alliance by 1,150.3% in the 3rd quarter. Capital Advisors Ltd. LLC now owns 2,063 shares of the pharmacy operator’s stock valued at $150,000 after acquiring an additional 1,898 shares in the last quarter. Finally, Livingston Group Asset Management CO operating as Southport Capital Management purchased a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $154,000. Institutional investors own 63.07% of the company’s stock.
Several analysts have weighed in on WBA shares. Loop Capital raised their price target on Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a “buy” rating in a report on Friday, October 12th. SunTrust Banks increased their price objective on Walgreens Boots Alliance to $75.00 and gave the company a “hold” rating in a research report on Friday, October 12th. ValuEngine upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Friday, October 12th. Citigroup raised their price target on Walgreens Boots Alliance from $69.00 to $76.00 and gave the stock a “neutral” rating in a research report on Friday, October 12th. Finally, Robert W. Baird raised their price target on Walgreens Boots Alliance from $69.00 to $71.00 and gave the stock a “neutral” rating in a research report on Friday, October 12th. Four investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $78.83.
Shares of Walgreens Boots Alliance stock opened at $70.12 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.36 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $67.17 billion, a PE ratio of 11.65, a price-to-earnings-growth ratio of 1.12 and a beta of 0.98. Walgreens Boots Alliance Inc has a 52 week low of $59.07 and a 52 week high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.43 by $0.03. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The company had revenue of $33.79 billion for the quarter, compared to the consensus estimate of $33.90 billion. During the same period in the previous year, the business earned $1.28 earnings per share. The firm’s revenue for the quarter was up 9.9% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 6.52 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 12th. Stockholders of record on Friday, February 15th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Thursday, February 14th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.51%. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.
In related news, Director Nancy M. Schlichting sold 7,050 shares of the stock in a transaction that occurred on Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total value of $555,610.50. Following the transaction, the director now owns 5,709 shares of the company’s stock, valued at $449,926.29. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 15.73% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: Why Dividend Stocks May Be Right for You